Allergan and tribe claim PTAB can’t decide on Restasis patents

Allergan and the Saint Regis Mohawk Tribe have argued that the Patent Trial and Appeal Board (PTAB) doesn’t have the jurisdiction to decide on the validity of patents concerning a dry-eye treatment while its recent decision is being appealed.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Allergan and tribe to appeal PTAB’s immunity decision

2 March 2018 The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

Americas

Native American tribe not entitled to sovereign immunity: PTAB

26 February 2018 The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.

Americas

Federal Circuit agrees with PTAB in optical patent appeal

21 January 2021 The US Court of Appeals for the Federal Circuit has affirmed a decision by the US Patent Trial and Appeal Board which centered on the validity of a patent for an ophthalmic illuminator.

More on this story

Americas

Allergan and tribe to appeal PTAB’s immunity decision

2 March 2018 The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

Americas

Native American tribe not entitled to sovereign immunity: PTAB

26 February 2018 The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.

Americas

Federal Circuit agrees with PTAB in optical patent appeal

More on this story

Americas

Allergan and tribe to appeal PTAB’s immunity decision

2 March 2018 The Saint Regis Mohawk Tribe and Allergan are planning to appeal against the Patent Trial and Appeal Board’s decision rejecting tribal sovereign immunity.

Americas

Native American tribe not entitled to sovereign immunity: PTAB

26 February 2018 The Patent Trial and Appeal Board rejected the Saint Regis Mohawk Tribe’s attempt to dismiss inter partes reviews related to dry-eye treatment Restasis late last week.

Americas

Federal Circuit agrees with PTAB in optical patent appeal